Skip to content

Smoking cessation lowers cardiovascular risk in D:A:D cohort

Tesamorelin safe and effective for fat accumulation in patients taking HIV treatment

Danes find more evidence linking abacavir treatment with increased risk of heart attack

FDA revises ddI product label to warn of serious liver side-effect

Genetic marker predicts fat loss due to d4T in Thai patients

Risk of kidney problems argues for 'strategic' use of tenofovir in higher risk patients

Bone loss following onset of menopause may put HIV-positive women at risk for fractures

Abacavir, ddI and two protease inhibitors remain associated with heart attacks in largest cohort study

Cardiovascular risks common amongst young US women with HIV